Search Results - "Peyton, Michael"
-
1
EGFR-Mediated Beclin 1 Phosphorylation in Autophagy Suppression, Tumor Progression, and Tumor Chemoresistance
Published in Cell (12-09-2013)“…Cell surface growth factor receptors couple environmental cues to the regulation of cytoplasmic homeostatic processes, including autophagy, and aberrant…”
Get full text
Journal Article -
2
Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells
Published in Molecular cell (05-12-2019)“…Intermediary metabolism in cancer cells is regulated by diverse cell-autonomous processes, including signal transduction and gene expression patterns, arising…”
Get full text
Journal Article -
3
Improper data practices erode the quality of global ecological databases and impede the progress of ecological research
Published in Global change biology (01-01-2024)“…The scientific community has entered an era of big data. However, with big data comes big responsibilities, and best practices for how data are contributed to…”
Get full text
Journal Article -
4
Dietary Niche Variation in an Invasive Omnivore: The Effects of Habitat on Feral Pig Resource Use in Hawai'i
Published in Ecology and evolution (01-10-2024)“…Invasive omnivores may have profound impacts on ecological communities through diet selection, particularly when their functional roles differ from those in…”
Get full text
Journal Article -
5
Dietary Niche Variation in an Invasive Omnivore: The Effects of Habitat on Feral Pig Resource Use in Hawai‘i
Published in Ecology and evolution (01-10-2024)“…ABSTRACT Invasive omnivores may have profound impacts on ecological communities through diet selection, particularly when their functional roles differ from…”
Get full text
Journal Article -
6
Proteomic profiling identifies dysregulated pathways in small cell lung cancer and novel therapeutic targets including PARP1
Published in Cancer discovery (01-09-2012)“…Small cell lung cancer (SCLC) is an aggressive malignancy distinct from non-small cell lung cancer (NSCLC) in its metastatic potential and treatment response…”
Get more information
Journal Article -
7
SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers
Published in Nature communications (19-01-2017)“…Mutations in the SMARCA4/BRG1 gene resulting in complete loss of its protein (BRG1) occur frequently in non-small cell lung cancer (NSCLC) cells. Currently, no…”
Get full text
Journal Article -
8
Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase Inhibitors
Published in Cancer cell (12-12-2016)“…Therapeutic drugs that block DNA repair, including poly(ADP-ribose) polymerase (PARP) inhibitors, fail due to lack of tumor-selectivity. When PARP inhibitors…”
Get full text
Journal Article -
9
Overcoming cancer cell resistance to Smac mimetic induced apoptosis by modulating cIAP-2 expression
Published in Proceedings of the National Academy of Sciences - PNAS (29-06-2010)“…Smac mimetics target cancer cells in a TNFα-dependent manner, partly via proteasome degradation of cellular inhibitor of apoptosis 1 (cIAP1) and cIAP2…”
Get full text
Journal Article -
10
PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR
Published in Cancer research (Chicago, Ill.) (15-04-2009)“…Clinical resistance to epidermal growth factor receptor (EGFR) inhibition in lung cancer has been linked to the emergence of the EGFR T790M resistance mutation…”
Get full text
Journal Article -
11
Synthetic lethal screen identification of chemosensitizer loci in cancer cells
Published in Nature (12-04-2007)“…Abundant evidence suggests that a unifying principle governing the molecular pathology of cancer is the co-dependent aberrant regulation of core machinery…”
Get full text
Journal Article -
12
PROTOCADHERIN 7 Acts through SET and PP2A to Potentiate MAPK Signaling by EGFR and KRAS during Lung Tumorigenesis
Published in Cancer research (Chicago, Ill.) (01-01-2017)“…Non-small cell lung cancer (NSCLC) is the leading cause of cancer-associated deaths worldwide. Given the efficacy of membrane proteins as therapeutic targets…”
Get full text
Journal Article -
13
SRBC/cavin-3 is a caveolin adapter protein that regulates caveolae function
Published in The EMBO journal (22-04-2009)“…Caveolae are a major membrane domain common to most cells. One of the defining features of this domain is the protein caveolin. The exact function of caveolin,…”
Get full text
Journal Article -
14
Telomerase-Mediated Strategy for Overcoming Non–Small Cell Lung Cancer Targeted Therapy and Chemotherapy Resistance
Published in Neoplasia (New York, N.Y.) (01-08-2018)“…Standard and targeted cancer therapies for late-stage cancer patients almost universally fail due to tumor heterogeneity/plasticity and intrinsic or acquired…”
Get full text
Journal Article -
15
An in vivo functional genomics screen of nuclear receptors and their co-regulators identifies FOXA1 as an essential gene in lung tumorigenesis
Published in Neoplasia (New York, N.Y.) (01-08-2020)“…Using a mini-library of 1062 lentiviral shRNAs targeting 40 nuclear hormone receptors and 70 of their co-regulators, we searched for potential therapeutic…”
Get full text
Journal Article -
16
SLC43A3 Is a Biomarker of Sensitivity to the Telomeric DNA Damage Mediator 6-Thio-2'-Deoxyguanosine
Published in Cancer research (Chicago, Ill.) (01-03-2020)“…Cell membrane transporters facilitate the passage of nucleobases and nucleosides for nucleotide synthesis and metabolism, and are important for the delivery of…”
Get full text
Journal Article -
17
Knockdown of oncogenic KRAS in non-small cell lung cancers suppresses tumor growth and sensitizes tumor cells to targeted therapy
Published in Molecular cancer therapeutics (01-02-2011)“…Oncogenic KRAS is found in more than 25% of lung adenocarcinomas, the major histologic subtype of non-small cell lung cancer (NSCLC), and is an important…”
Get full text
Journal Article -
18
Combination treatment with MEK and AKT inhibitors is more effective than each drug alone in human non-small cell lung cancer in vitro and in vivo
Published in PloS one (29-11-2010)“…AZD6244 and MK2206 are targeted small-molecule drugs that inhibit MEK and AKT respectively. The efficacy of this combination in lung cancer is unknown. Our…”
Get full text
Journal Article -
19
Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines
Published in PloS one (24-02-2009)“…Deregulation of EGFR signaling is common in non-small cell lung cancers (NSCLC) and this finding led to the development of tyrosine kinase inhibitors (TKIs)…”
Get full text
Journal Article -
20
STAT3 Mediates Resistance to MEK Inhibitor through MicroRNA miR-17
Published in Cancer research (Chicago, Ill.) (15-05-2011)“…AZD6244 is a small molecule inhibitor of the MEK (MAP/ERK kinase) pathway currently in clinical trials. However, the mechanisms mediating intrinsic resistance…”
Get full text
Journal Article